Frew, Anthony J.
Pfaar, Oliver
Funding for this research was provided by:
University of Sussex
Article History
Received: 12 March 2018
Accepted: 16 March 2018
First Online: 24 May 2018
Conflict of interest
: A.J. Frew has conducted clinical trials of subcutaneous and sublingual immunotherapy with several pharmaceutical companies including ALK-Abello, Allergopharma and Stallergenes but has no other current interests to report. O. Pfaar reports grants and personal fees from ALK-Abelló, grants and personal fees from Allergopharma, grants and personal fees from Stallergenes Greer, grants and personal fees from HAL Allergy Holding B.V./HAL Allergie GmbH, grants and personal fees from Bencard Allergie GmbH/Allergy Therapeutics, grants and personal fees from Lofarma, grants from Biomay, grants from Nuvo, grants from Circassia, grants and personal fees from Biotech Tools S.A., grants and personal fees from Laboratorios LETI/LETI Pharma, personal fees from Novartis Pharma, personal fees from MEDA Pharma, grants and personal fees from Anergis S.A., personal fees from Mobile Chamber Experts (a GASuperscript removedLEN Partner), personal fees from Pohl-Boskamp, personal fees from Indoor Biotechnologies, grants from Glaxo Smith Kline, outside the submitted work.